Literature DB >> 30201085

Influence of apheresis collection device and container on the storage properties of platelets in 90% PAS-5/10% plasma.

Stephen J Wagner1, Cheryl A Hapip1, Annette Turgeon1, Lenora Abel1, Nadine Kaelber1.   

Abstract

BACKGROUND: The storage properties of apheresis platelets suspended in the experimental additive solution PAS-5 and 10% plasma may be affected by the collection instrument or storage container. METHODS AND EXPERIMENTAL
DESIGN: The same consenting 12 donors provided A or T platelets with concurrent plasma on four occasions in 100% plasma. Following collection and resting, the platelets were centrifuged, and plasma was expressed and resuspended in PAS-5 to yield units with 10% plasma. Platelets were either maintained in the original storage container or transferred to another of the manufacturer's storage containers. On days 1, 5 and 7, units were assayed for an array of in vitro tests.
RESULTS: Average unit volume, yield and percent plasma was 291±11 mL, 3.7±0.4×1011, and 10.3±0.7%, respectively, and were comparable between collections with either of the apheresis instruments and stored with either of the manufacturer's containers. Day 1 platelet activation (CD62P+) was 40±22% and was similar in either of the collection instruments or containers. Except for pH (days 1, 5), CO2 (days 1, 5, 7), and extent of shape change (day 5), every other in vitro parameter was similar between apheresis platforms or the manufacturer's container. pH values of all units on all days of storage were ≥6.8, except one unit that was collected on T and stored in an A container, which had pH values of 6.8 and 5.7 on days 5 and 7, respectively. DISCUSSION: Storage of platelets suspended in PAS-5 with 10% plasma is feasible in the original manufacturer's container for seven days. Based on CO2 levels, T containers have greater gas exchange than A containers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201085      PMCID: PMC6596381          DOI: 10.2450/2018.0136-18

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  20 in total

1.  Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65% platelet additive solution III/35% plasma and including periods without agitation under simulated shipping conditions.

Authors:  Gary Moroff; James Kurtz; Shalini Seetharaman; Andrey Skripchenko; Helen Awatefe; Dedeene Thompson-Montgomery; Andrew Myrup; Stephen J Wagner
Journal:  Transfusion       Date:  2011-10-20       Impact factor: 3.157

2.  Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.

Authors:  Stephen J Wagner; Andrew Myrup; Helen Awatefe; Dedeene Thompson-Montgomery; Junichi Hirayama; Andrey Skripchenko
Journal:  Transfusion       Date:  2008-08-27       Impact factor: 3.157

3.  Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.

Authors:  Stephen J Wagner; Shalini Seetharaman; James Kurtz
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

4.  A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion.

Authors:  S Holme; G Moroff; S Murphy
Journal:  Transfusion       Date:  1998-01       Impact factor: 3.157

5.  The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Authors:  Aaron A R Tobian; Alice K Fuller; Kristin Uglik; Daniel J Tisch; Prabhakar D Borge; Richard J Benjamin; Paul M Ness; Karen E King
Journal:  Transfusion       Date:  2013-11-19       Impact factor: 3.157

6.  Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS).

Authors:  Sherrill J Slichter; Jill Corson; Mary Kay Jones; Todd Christoffel; Esther Pellham; S Lawrence Bailey; Doug Bolgiano
Journal:  Blood       Date:  2013-11-20       Impact factor: 22.113

7.  In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5.

Authors:  Katherine Radwanski; Stephen J Wagner; Andrey Skripchenko; Kyungyoon Min
Journal:  Transfusion       Date:  2011-07-25       Impact factor: 3.157

8.  Automated cold temperature cycling improves in vitro platelet properties and in vivo recovery in a mouse model compared to continuous cold storage.

Authors:  Andrey Skripchenko; Monique P Gelderman; Helen Awatefe; Annette Turgeon; Dedeene Thompson-Montgomery; Chunrong Cheng; Jaroslav G Vostal; Stephen J Wagner
Journal:  Transfusion       Date:  2015-09-01       Impact factor: 3.157

9.  A comparison of adverse reaction rates for PAS C versus plasma platelet units.

Authors:  Claudia S Cohn; James Stubbs; Joseph Schwartz; Richard Francis; Cheryl Goss; Melissa Cushing; Beth Shaz; David Mair; Barbara Brantigan; W Andrew Heaton
Journal:  Transfusion       Date:  2014-04-16       Impact factor: 3.157

10.  Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.

Authors:  Frédéric Garban; Audrey Guyard; Helene Labussière; Claude-Eric Bulabois; Tony Marchand; Christiane Mounier; Denis Caillot; Jacques-Olivier Bay; Valérie Coiteux; Aline Schmidt-Tanguy; Catherine Le Niger; Christine Robin; Patrick Ladaique; Simona Lapusan; Eric Deconinck; Carole Rolland; Alison M Foote; Anne François; Chantal Jacquot; René Tardivel; Pierre Tiberghien; Jean-Luc Bosson
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.